Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-22T15:25:32.222Z Has data issue: false hasContentIssue false
  • English
  • Français

HBV-DNA, HBeAg/anti-HBe serological status in hepatitis B chronic individuals from central Italy

Published online by Cambridge University Press:  15 May 2009

M. Rapicetta ,
V. Di Nardo ,
C. Rozera ,
G. Marinucci ,
D. Francisci ,
B. Sarrecchia ,
C. Ricci  and
F. Albertoni
M. Rapicetta*
Affiliation:
Department of Virology, Istituto Superiore di Sanità, Rome, Italy
V. Di Nardo
Affiliation:
Department of Infectious Diseases, Civil Hospital, Rieti, Italy
C. Rozera
Affiliation:
Department of Virology, Istituto Superiore di Sanità, Rome, Italy
G. Marinucci
Affiliation:
Department of Immunology, Hospital ‘s. Giacomo’, Rome, Italy
D. Francisci
Affiliation:
Institute of Infectious Diseases University of Perugia, Italy
B. Sarrecchia
Affiliation:
Department of Virology, Istituto Superiore di Sanità, Rome, Italy
C. Ricci
Affiliation:
Civil Hospital, Tivoli, Italy
F. Albertoni
Affiliation:
Regional Epidemiologic Unit, Rome, Italy
*
* M. Rapicetta, Istituto Superiore di Sanità, Department of Virology, V. le Regina Elena, 229-00161, Rome, Italy.
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A population of 488 HBsAg carrier individuals, from central Italy, classified on the basis of biochemical, clinical and histological parameters, was analysed for the presence of HBV-DNA in serum and its relationship with HBeAg/anti-HBe markers. The prevalence of HBV-DNA was 32·8% in chronic patients with biopsy-proven liver disease, and 20 and 4·3% respectively in asymptomatic carriers with and without altered ALT levels. The values in chronic patients were correlated with the histological activity.

Concordance of HBV-DNA presence and HBeAg positivity was observed in only 61·4% of cases. However HBV-DNA prevalence in sera of anti-HBe positive individuals was very low in asymptomatic carriers with normal ALT levels (2·5%). Higher values were observed in anti-HBe positive chronic patients (15·8%) and in carriers occasionally found with changes in ALT without any other clinical sign of illness (16·7%). These data would indicate that HBV-DNA is the serological marker which is most closely related to liver disease.

Type
Research Article
Information
Epidemiology & Infection , Volume 104 , Issue 3 , June 1990 , pp. 511 - 518
Copyright
Copyright © Cambridge University Press 1990

References

REFERENCES

1.Karayannis, P, Fowler, MJF, Lok, ASF, Greenfield, C, Monjardino, J, Thomas, HC. Detection of serum HBV-DNA by molecular hybridization: correlation with HBeAg/anti-HBe status, racial origin, liver histology and hepatocellular carcinoma. J Hepatol 1985; 1: 99–106.Google Scholar
2.Tur-Kaspa, R, Keshet, E, Eliakim, M, Shouval, D. Detection and characterization of HBV-DNA in serum of HBe antigen-negative HBsAg carriers. J Med Virol 1984; 14: 17–26.CrossRefGoogle ScholarPubMed
3.Yun-Fan, L, Chia-Ming, C, Deng-Yn, L, I-Shyan, S, Chaur-Young, Y, Miau-Ju, H. Age specific prevalence and significance of HBeAg and anti-HBe in chronic hepatitis B virus Infection in Taiwan: A comparison among asymptomatic carriers, chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. J Med Virol 1984; 13: 385–91.Google Scholar
4.Morace, G, Von der, Helm K, Jilg, W, Deinhardt, F. Detection of hepatitis B virus DNA in serum by a rapid filtration-Hybridization assay. J Virol Meth 1985; 12: 235–42.CrossRefGoogle ScholarPubMed
5.BianchiL, De L, De, Groote, J, Desmet, VJ et al. , Acute and chronic hepatitis revisited. Lancet 1977; II: 914–9.Google Scholar
6.Berris, B, Sampliener, RE, Sooknanan, R, Feinman, SV. Hepatitis B virus DNA in asymptomatic HBsAg carriers: comparison with HBeAg anti HBe status. J Med Virol 1987; 23: 233–9.CrossRefGoogle ScholarPubMed
7.Yun-Fan, L, Chia, CP, Chia-Ming, C, I-Shyan, S, Mian-Ju, H. Changes of serum hepatitis B virus DNA in two types of clinical events preceding spontaneous hepatitis Be antigen seroconversion in chronic type B Hepatitis. Hepatol 1987; 7: 1–3.Google Scholar
8.Bonino, F, Rosina, F, Rizzetto, M et al. , Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti HBe. Gastroenterol 1986; 90: 1268–73.CrossRefGoogle ScholarPubMed
9.Carloni, G, Colloca, S, Delfini, C, Manzin, A, Clementi, M, Galimbert, F. Detection of HBV infectivity by spot hybridization in HBeAg-negative chronic carriers: HBV-DNA in sera from asymptomatic and symptomatic subjects. J Med Virol 1987; 21: 15–23.CrossRefGoogle ScholarPubMed
10.Fattovich, G, Rugge, M, Brollo, L et al. , Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B. Hepatol 1986; 6: 167–72.CrossRefGoogle ScholarPubMed
11.Harrison, TJ, Bal, V, Wheeler, EG, Meacok, TJ, Zuckerman, AJ. Hepatitis B virus DNA and e antigen in serum from blood donors in the United Kingdom positive for hepatitis B surface antigen. Br Med J 1985; 290: 663–4.CrossRefGoogle Scholar
12.Kashiwagi, S, Hayashi, J, Nomura, H et al. , Age-specific prevalence of HBeAg and anti-HBe among asymptomatic HbsAg carriers in Okinawa and Kyushu, Japan. Microbiol Immunol 1986; 30; 675–82.CrossRefGoogle ScholarPubMed
13.Wu, JC, Lee, SD, Wang, JY et al. , Analysis of the DNA of hepatitis B virus in sera of Chinese patients infected with hepatitis B. J Infect Dis 1986; 153: 974–6.CrossRefGoogle ScholarPubMed
14.Ding-Shinn, Chen, Ming-Yang, Lai, Shen-Chung, Lee, Pei-Ming, Yang, Jin Chuan, Shew, Juei-Low, Sung.Serum HBsAg, HbeAg. antiHBe and hepatitis B Viral DNA in asymptomatic carriers in Taiwan. J Med Virol 1986; 19: 87–94.Google Scholar
15.Rizzetto, M, Canese, MG, Gerin, JL., London, WT, Sey, DL, Purcell, RH. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis 1980; 141: 590–602.CrossRefGoogle ScholarPubMed
16.Heijitink, RA, Smal, P, Ten, Kate FJ, Kmining, J, Schalm, SW. Detection of HBV-DNA in liver biopsy and serum: its significance in the selection of hepatitis B patients for antiviral therapy. Antiviral Res 1987; 7: 329–40.CrossRefGoogle Scholar